A University of Alabama at Birmingham biotech startup received $1.2 million to continue research toward treating a chronic kidney disease.
News
- Birmingham biotech company receives $1.2M toward research - The Business Journals
- Third Rock to use new $1.1 billion fund to invest in outside companies for 1st time
But in a break from tradition, the biotech-focused firm also will use a portion of its fund to make investments in companies that it had no hand ...
- Inflation, rising interest rates, bear market likely to affect commercial real estate deals — but how?
San Antonio Business Journal. Limited Time Offer ... What slowdown in biotech spells for life-sciences real estate sector.
- Mejores momentos de la procesión de San Antonio en Venta de San Antonio (Alcaudete) - YouTube
Mejores momentos de la procesión de San Antonio en Venta de San Antonio ... Innovation® with Sabrina Johnson, President & CEO, Daré Bioscience.
- Top-line results for bexmarilimab across 10 advanced solid tumors - The Pharma Letter
London-listed Finnish biotech firm Faron Pharmaceuticals (AIM: FARN) today ... Mays Cancer Center, University of Texas Health, San Antonio.